ライフサイエンスコーパス: cholestatic hepatitis

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 he most common clinical pattern was a severe cholestatic hepatitis.

2 those with advanced fibrosis (F3-F4) and/or cholestatic hepatitis.

3 hepatic impairment; and those with fibrosing cholestatic hepatitis.

4 atients with recurrent advanced fibrosis and cholestatic hepatitis.

5 me with growth failure or transient neonatal cholestatic hepatitis.

6 ajor cause of hepatocyte injury in fibrosing cholestatic hepatitis.

7 riants, particularly in those with fibrosing cholestatic hepatitis.

8 P-A, CTP-B, or CTP-C cirrhosis; or fibrosing cholestatic hepatitis.

9 d in 51% with advanced fibrosis and 44% with cholestatic hepatitis.

10 d in 22% with advanced fibrosis and 33% with cholestatic hepatitis.

11 irment, and by all 6 patients with fibrosing cholestatic hepatitis.

12 cute (9%) and chronic cholestasis (10%), and cholestatic hepatitis (29%).

13 e patients with advanced fibrosis and 9 with cholestatic hepatitis (74% men, 57% genotype 1a, 63% pre

14 and 4 patients (17%) developed severe acute cholestatic hepatitis (ACH).

15 All five patients with fibrosing cholestatic hepatitis achieved SVR12 (100%, 90% CI 55-10

16 Nine patients presented with cholestatic hepatitis and 12 patients presented with hep

17 (Mdr2-KO) mice spontaneously develop chronic cholestatic hepatitis and fibrosis that is eventually fo

18 transplantation develop a severe progressive cholestatic hepatitis and liver failure.

19 inflammation-mediated HCC, develops chronic cholestatic hepatitis at an early age and HCC at an adul

20 Severe recurrent cholestatic hepatitis C after liver transplantation has

21 Four cases of severe recurrent cholestatic hepatitis C treated with a combination of in

22 topathology consistent with severe recurrent cholestatic hepatitis C.

23 cies may be one mechanism by which fibrosing cholestatic hepatitis develops after liver transplantati

24 Twenty-seven percent had fibrosing cholestatic hepatitis/early aggressive HCV in the graft,

25 hepatitis C, including those with fibrosing cholestatic hepatitis (FCH) and decompensated cirrhosis

26 Fibrosing cholestatic hepatitis (FCH) has recently been described

27 Fibrosing cholestatic hepatitis (FCH) is a rapidly progressive for

28 Bile duct loss during acute cholestatic hepatitis is an ominous early indicator of p

29 th early graft failure, similar to fibrosing cholestatic hepatitis seen in some transplant patients w

30 type 1 HCV and advanced fibrosis (F3-4/4) or cholestatic hepatitis treated with telaprevir- or bocepr

31 All 10 developed severe progressive cholestatic hepatitis, with a mean rise in bilirubin to

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。